Effect and safety of sorafenib in patients with intermediate hepatocellular carcinoma who received t

• 作 者: Xue-Fen Lei Yang Ke Tian-Hao B
• 机 构: DepartmentofMedicalOncology,DepartmentofHepatobiliarySurgery,TheMentalHealthCenterofKunmingMedicalUn
• 出 处: 世界临床病例杂志
• 发表日期: 2018年5期
• 关键词: SORAFENIB Hepatocellular carcinoma Transarterial CHEMOEMBOLIZATION Overall survi

AIM To evaluate the safety and efficacy of sorafenib plus transarterial chemoembolization(TACE)treatment for intermediate hepatocellular carcinoma(HCC).METHODS Sixty-seven patients with intermediate-stage[Barcelona Clinic liver cancer stage B(BCLC-B)]HCC